Skip to main content

[vc_row][vc_column width="1/4"][vc_single_image image="23417" img_size="medium" css=""][/vc_column][vc_column width="3/4"][vc_column_text css=""]A novel instrument for detecting cancer cells in the blood could lead to individualized cancer treatments for patients suffering metastasis. Developed by a Massachusetts General Hospital team led by Daniel Haber, M.D., Ph.D., a renowned cancer scientist supported by...

[vc_row][vc_column width="1/4"][vc_single_image image="23034" img_size="large" alignment="center" style="vc_box_shadow_border"][/vc_column][vc_column width="3/4"][vc_column_text css=""]You wouldn’t think it, but the science cannot be denied: One of the newest and most promising drug candidates for cancer was actually developed all the way back in 1972. For malaria. “There were some hints in the literature,...

At least eight National Foundation for Cancer Research (NFCR) scientists will be on hand for the 54th annual meeting of the American Society of Clinical Oncology (ASCO), most prominently, Alice Shaw, M.D., Ph.D. They will join over 30,000 physicians, researchers, administrators and other professionals for...